EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Competing mortality and the interpretation of similar non-fatal MACE risk with second-generation BTK inhibitors

Hasan Burak Isleyen, Zehra Sucuoglu

European Heart Journal – Cardio-Oncology · 2026

DOI: 10.1093/ehjco/aabag014 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Heart Journal – Cardio-Oncology, 2026. Verfasst von Hasan Burak Isleyen und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Isleyen, H. B., & Sucuoglu, Z. (2026). Competing mortality and the interpretation of similar non-fatal MACE risk with second-generation BTK inhibitors. European Heart Journal – Cardio-Oncology. https://doi.org/10.1093/ehjco/aabag014

Vancouver

Isleyen HB, Sucuoglu Z. Competing mortality and the interpretation of similar non-fatal MACE risk with second-generation BTK inhibitors. European Heart Journal – Cardio-Oncology. 2026. doi:10.1093/ehjco/aabag014

BibTeX
@article{Isleyen2026,
  author = {Isleyen, Hasan Burak and Sucuoglu, Zehra},
  title = {Competing mortality and the interpretation of similar non-fatal MACE risk with second-generation BTK inhibitors},
  journal = {European Heart Journal – Cardio-Oncology},
  year = {2026},
  doi = {10.1093/ehjco/aabag014}
}
Kostenlos starten →